{"id":446567,"title":"Notice of Amendment: Revision of Brimonidine on the Prescription Drug List (PDL) - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-03","captureTimestamp":"2026-01-03T12:16:21.097000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/amendment-revision-brimonidine.html?wbdisable=false","snippet":"Notice of Amendment: Revision of Brimonidine on the Prescription Drug List (PDL) May 16, 2022 Our file number: 22-105587-718 The purpose of this Notice of Amendment is to notify that Health Canada has revised the listing of \"brimonidine or its salts\" on the Prescription Drug List…","rawSnapshotUrl":"/api/snapshots/raw/446567","browseUrl":"https://replay.healtharchive.ca/job-6/20260103121621/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/amendment-revision-brimonidine.html?wbdisable=false#ha_snapshot=446567","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}